MDxHealth SA (NASDAQ: MDXH) reported Q2 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $27.21 million versus the consensus estimate of $25.89 million.

GUIDANCE:

MDxHealth SA sees FY2026 revenue of $110-115 million, versus the consensus of $110.6 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.